Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/04/2022 11 1
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Elbasvir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 2 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 8 0
MI-30 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021 1 0
MI-09 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021 1 0
S-FL-opt/S1 recombinant protein Potential treatment - pre-clinical evidence Experimental Vaccine Feb/08/2021 1 0
Excel (.xslx) CSV (.csv)